Determination of In Vitro Antimicrobial Susceptibility for Lefamulin (Pleuromutilin) for <i>Ureaplasma</i> Spp. and <i>Mycoplasma hominis</i>
Lefamulin is the first of the pleuromutilin class of antimicrobials to be available for therapeutic use in humans. Minimum inhibitory concentrations of lefamulin were determined by microbroth dilution for 90 characterised clinical isolates (25 <i>Ureaplasma</i> <i>parvum</i>,...
Enregistré dans:
Auteurs principaux: | Oliver Spiller-Boulter, Susanne Paukner, Ian Boostrom, Kirsty Sands, Edward A. R. Portal, Owen B. Spiller |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bc719c3f63ca4dcc8b8fbc8c3bbac62d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Defining Fluoroquinolone Resistance-Mediating Mutations from Non-Resistance Polymorphisms in <i>Mycoplasma hominis</i> Topoisomerases
par: Martin Sharratt, et autres
Publié: (2021) -
THE METHODS OF LABORATORY DIAGNOSTICS OF UROGENITAL INFECTIONS ASSOCIATED WITH MYCOPLASMA HOMINIS AND UREAPLASMA SPP.
par: O. V. Zarucheynova
Publié: (2015) -
An Elderly COVID-19 Patient with Community-Acquired <i>Legionella</i> and <i>Mycoplasma</i> Coinfections: A Rare Case Report
par: Sari T. S. Alhuofie
Publié: (2021) -
Utilidad de la reacción de polimerasa en cadena convencional para la detección de Mycoplasma hominis, Ureaplasma spp. y Trichomonas vaginalis en muestras genitales de mujeres en consulta ambulatoria
par: Alarcón,Gonzalo, et autres
Publié: (2016) -
The <i>aadE</i>*-<i>sat4</i>-<i>aphA-3</i> Gene Cluster of <i>Mycoplasma bovirhinis</i> HAZ141_2 Undergoes Genomic Rearrangements Influencing the Primary Promoter Sequence
par: Inna Lysnyansky, et autres
Publié: (2021)